Show simple item record

Cholinergic enzymatic activity of cerebrospinal fluid of patients with various neurologic diseases

dc.contributor.authorJohnson, S.en_US
dc.contributor.authorDomino, Edward F.en_US
dc.date.accessioned2006-04-17T16:20:10Z
dc.date.available2006-04-17T16:20:10Z
dc.date.issued1971-12en_US
dc.identifier.citationJohnson, S., Domino, E. F. (1971/12)."Cholinergic enzymatic activity of cerebrospinal fluid of patients with various neurologic diseases." Clinica Chimica Acta 35(2): 421-428. <http://hdl.handle.net/2027.42/33512>en_US
dc.identifier.urihttp://www.sciencedirect.com/science/article/B6T57-47PRF20-1P3/2/d5c3bf819c0520830d055877d546f73cen_US
dc.identifier.urihttps://hdl.handle.net/2027.42/33512
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=5125328&dopt=citationen_US
dc.description.abstractThe cerebrospinal fluid (CSF) of normal humans contains both true and pseudocholinesterases and choline acetyl transferase (choline acetylase) detectable by radiochemical assay. Elevations of total cholinesterase, pseudocholinesterase, and true cholinesterase occur in brain tumors, meningitis, Guillain-Barre disease, hydrocephalus, and brain abscess. However, the non-specificity and inconstancy of CSF cholinesterase changes in neurologic diseases limit its clinical usefulness.Choline acetylase levels in CSF are normally 0.187 +/- 0.073 nmoles ACh/ml CSF/ min. One patient with meningioma had a level of 0.680. Unlike cholinesterase, choline acetylase levels in blood are lower than in CSF. Hence, the origin of elevated CSF choline acetylase activity is probably in the nervous system.en_US
dc.format.extent641478 bytes
dc.format.extent3118 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.language.isoen_US
dc.publisherElsevieren_US
dc.titleCholinergic enzymatic activity of cerebrospinal fluid of patients with various neurologic diseasesen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelPathologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Pharmacology, University of Michigan, Ann Arbor and Lafayette Clinic, Detroit, Michigan, U.S.A.en_US
dc.contributor.affiliationumDepartment of Pharmacology, University of Michigan, Ann Arbor and Lafayette Clinic, Detroit, Michigan, U.S.A.en_US
dc.identifier.pmid5125328en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/33512/1/0000010.pdfen_US
dc.identifier.doihttp://dx.doi.org/10.1016/0009-8981(71)90216-6en_US
dc.identifier.sourceClinica Chimica Actaen_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.